Acadia: Q2 Earnings Snapshot
By AP News
Published - Aug 06, 2024, 04:42 PM ET
Last Updated - Aug 06, 2024, 04:42 PM EDT
SAN DIEGO (AP) — SAN DIEGO (AP) — Acadia Pharmaceuticals Inc. (ACAD) on Tuesday reported second-quarter profit of $33.4 million.
The San Diego-based company said it had net income of 20 cents per share.
The results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 16 cents per share.
The drugmaker posted revenue of $242 million in the period, which also topped Street forecasts. Seven analysts surveyed by Zacks expected $235.3 million.
